Cara Therapeutics Appoints Mani Mohindru As CFO

(RTTNews) - Cara Therapeutics Inc. (CARA) said that it appointed Mani Mohindru as Chief Financial Officer and Chief Strategy Officer, effective August 15, 2017.

Josef Schoell, who has held the CFO position at Cara for more than a decade, will be retiring.

Mohindru brings more than a decade of leadership experience in the biopharmaceutical industry to Cara. Most recently, she served as Chief Strategy Officer at Curis, Inc. (CRIS). Earlier in her career, Dr. Mohindru spent several years as an equity research analyst covering the biotechnology sector at ThinkEquity, LLC, Credit Suisse and UBS.